Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intra‑arterial and intravenous use. It enhances X‑ray attenuation during imaging procedures, allowing clearer visualization of vascular structures and organs in patients undergoing diagnostic radiology and therapeutic planning.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics, imaging centres and research institutions worldwide, adhering to stringent quality standards and providing full regulatory documentation for export to EU and other markets.

Iomeron is used as an iodinated contrast agent to improve radiographic visualization in various imaging procedures. - Angiography: enhances visualization of blood vessels for diagnostic and interventional procedures. - Computed tomography (CT) imaging: provides high‑contrast detail of soft tissues and organs. - Myelography: improves delineation of the spinal canal and nerve roots. - Urography: highlights urinary tract structures for functional assessment. - Contrast‑enhanced radiographic procedures: facilitates clearer imaging in a range of X‑ray based studies.

Iomeron may be associated with a range of adverse reactions, from mild to severe.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Metallic taste in the mouth. - Nausea or vomiting. - Transient urticaria or itching.

Serious or Rare Side Effects: - Anaphylactoid or severe allergic reaction, including bronchospasm. - Acute kidney injury, particularly in patients with pre‑existing renal dysfunction. - Thyroid dysfunction such as hyper‑ or hypothyroidism.

Prior to administration, several safety measures should be considered. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Screen for iodine or contrast allergy: obtain detailed allergy history. - Ensure adequate hydration: encourage fluid intake pre‑ and post‑procedure. - Use the lowest effective dose: tailor volume to imaging requirement. - Monitor thyroid status: consider thyroid function tests in at‑risk patients. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Iomeron can interact with certain medications, requiring attention to avoid or monitor effects.

Major Interactions (Avoid): - Metformin: concurrent use may increase risk of lactic acidosis in renal impairment. - Nephrotoxic agents (e.g., aminoglycosides, high‑dose NSAIDs): may exacerbate contrast‑induced nephropathy. - Thyroid hormone therapy: iodinated contrast can alter thyroid hormone levels.

Moderate Interactions (Monitor Closely): - Diuretics: may affect fluid balance and renal clearance of contrast. - ACE inhibitors or ARBs: monitor blood pressure and renal function during contrast administration. - Beta‑blockers: may mask signs of anaphylactoid reactions.